Literature DB >> 2271630

Simple method for selecting catalytic monoclonal antibodies that exhibit turnover and specificity.

D S Tawfik1, R R Zemel, R Arad-Yellin, B S Green, Z Eshhar.   

Abstract

Monoclonal antibodies were raised against a mono-p-nitrophenyl phosphonate ester to elicit catalytic antibodies capable of hydrolyzing the analogous p-nitrophenyl ester or carbonate. Potential catalytic antibody producing clones were selected, by use of a competitive inhibition assay, on the basis of their affinity for a "short" transition-state analogue, a truncated hapten which maximizes the relative contribution of the transition-state structural elements to binding. Of 30-40 clones that would have been examined on the basis of hapten binding alone, 7 were selected and 4 of these catalyzed the hydrolysis of the relevant p-nitrophenyl ester. This competitive inhibition technique represents a general approach for selecting potential catalytic antibodies and significantly increases the probability of obtaining efficient catalytic monoclonal antibodies. Further study of the catalytic antibodies revealed significant rate enhancement (kcat/kuncat approximately 10(4)) and substrate specificity for the hydrolysis of the analogous ester and, for three of the antibodies, of the analogous carbonate. The antibodies displayed turnover, an essential feature of enzymes. Evidence that catalysis occurred at the antibody combining sites was provided by the identity of the binding and the catalysis-inhibition specificity patterns.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2271630     DOI: 10.1021/bi00494a023

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  catELISA: a facile general route to catalytic antibodies.

Authors:  D S Tawfik; B S Green; R Chap; M Sela; Z Eshhar
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

Review 2.  In vivo versus in vitro screening or selection for catalytic activity in enzymes and abzymes.

Authors:  J Fastrez
Journal:  Mol Biotechnol       Date:  1997-02       Impact factor: 2.695

3.  Diminishing returns and tradeoffs constrain the laboratory optimization of an enzyme.

Authors:  Nobuhiko Tokuriki; Colin J Jackson; Livnat Afriat-Jurnou; Kirsten T Wyganowski; Renmei Tang; Dan S Tawfik
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

4.  Prodrug activation via catalytic antibodies.

Authors:  H Miyashita; Y Karaki; M Kikuchi; I Fujii
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

Review 5.  Catalytic antibodies: a critical assessment.

Authors:  D S Tawfik; Z Eshhar; B S Green
Journal:  Mol Biotechnol       Date:  1994-02       Impact factor: 2.695

Review 6.  Immune recognition, antigen design, and catalytic antibody production.

Authors:  A Tramontano
Journal:  Appl Biochem Biotechnol       Date:  1994 May-Jun       Impact factor: 2.926

Review 7.  Hapten design for the generation of catalytic antibodies.

Authors:  N R Thomas
Journal:  Appl Biochem Biotechnol       Date:  1994 May-Jun       Impact factor: 2.926

8.  Crystal structure of the complex of a catalytic antibody Fab fragment with a transition state analog: structural similarities in esterase-like catalytic antibodies.

Authors:  J B Charbonnier; E Carpenter; B Gigant; B Golinelli-Pimpaneau; Z Eshhar; B S Green; M Knossow
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

9.  Toward antibody-directed "abzyme" prodrug therapy, ADAPT: carbamate prodrug activation by a catalytic antibody and its in vitro application to human tumor cell killing.

Authors:  P Wentworth; A Datta; D Blakey; T Boyle; L J Partridge; G M Blackburn
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-23       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.